Moreover, rapamycin, a well-established inhibitor of mTOR/p70S6K, inhibits resistin-induced ovarian cancer cell proliferation by blocking 70 kDa S6 kinase, which is a key element of mTOR signaling [71]. Here, MTOR is linked to ovarian carcinoma.